losartan has been researched along with Acute Disease in 43 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Acute Disease: Disease having a short and relatively severe course.
Excerpt | Relevance | Reference |
---|---|---|
"To study the pro-apoptotic effect of Losartan on myocardial cells after acute myocardial infarction (AMI) in rats." | 7.96 | Losartan promotes myocardial apoptosis after acute myocardial infarction in rats through inhibiting Ang II-induced JAK/STAT pathway. ( Liu, R; Xin, LH; Yang, XW, 2020) |
"To study the effect of an angiotensin II type 1 receptor antagonist, losartan, on cytokine expression, kidney growth and renal scarring in experimental acute pyelonephritis." | 7.70 | Angiotensin II type 1 receptor antagonist (losartan) down-regulates transforming growth factor-beta in experimental acute pyelonephritis. ( Bakhiet, M; Brauner, A; Burman, LG; Jaremko, G; Khalil, A; Tullus, K, 2000) |
"Losartan, a recently developed nonpeptide angiotensin II (AII) receptor antagonist, was orally administered for 14 days to mice with viral myocarditis, beginning 7 days after encephalomyocarditis virus inoculation." | 7.69 | Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus. ( Araki, M; Imai, S; Kanda, T; Kobayashi, I; Murata, K; Suzuki, T, 1995) |
"To assess the efficacy of losartan (2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphe nyl-4-yl)methyl]imidazole, potassium salt), an angiotensin II receptor antagonist, on acute myocardial ischemia, 36 four-month-old spontaneously hypertensive rats were used." | 7.69 | Losartan attenuates myocardial ischemia-induced ventricular arrythmias and reperfusion injury in spontaneously hypertensive rats. ( Ding, YA; Lee, YM; Peng, YY; Yen, MH, 1997) |
"Contributions to the understanding of acute renal failure (ARF) pathogenesis have not been translated into an effective clinical therapy." | 5.35 | Effects of losartan pretreatment in an experimental model of ischemic acute kidney injury. ( Bobadilla, NA; Cortés-González, C; Cruz, C; Elías, MM; González-Bobadilla, Y; Molinas, SM; Monasterolo, LA; Trumper, L, 2009) |
"Both enalapril and losartan treatment reduced the acute albuminuria, measured 1 day after injection of a monoclonal antibody against aminopeptidase A, by 91% and 83%, respectively." | 5.29 | Inhibition of aminopeptidase A activity causes an acute albuminuria in mice: an angiotensin II-mediated effect? ( Assmann, KJ; de Jong, AS; Dijkman, HB; Koene, RA; Mentzel, S; van Son, JP; Wetzels, JF, 1996) |
"To report a case of acute pancreatitis in a patient receiving a combination formulation of irbesartan and hydrochlorothiazide (HCTZ)." | 4.81 | Acute pancreatitis associated with angiotensin II receptor antagonists. ( Bassett, ML; Fisher, AA, 2002) |
"To study the pro-apoptotic effect of Losartan on myocardial cells after acute myocardial infarction (AMI) in rats." | 3.96 | Losartan promotes myocardial apoptosis after acute myocardial infarction in rats through inhibiting Ang II-induced JAK/STAT pathway. ( Liu, R; Xin, LH; Yang, XW, 2020) |
" The purpose of this study was to investigate the anti-inflammatory effect of a selective AT1 receptor antagonist, losartan, on endotoxin-induced uveitis (EIU) and compare the effect on experimental autoimmune uveoretinitis (EAU)." | 3.74 | Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats. ( Iwabuchi, K; Iwata, D; Jin, XH; Kitaichi, N; Miyazaki, A; Morohashi, T; Ohgami, K; Ohno, S; Onoé, K, 2008) |
"Unilateral ureteral obstruction in pigs is associated with an enhanced, de novo generation of angiotensin II from the ipsilateral kidney." | 3.71 | Losartan attenuates renal vasoconstriction in response to acute unilateral ureteral occlusion in pigs. ( Djurhuus, JC; Frøkiaer, J; Hvistendahl, JJ; Pedersen, EB; Pedersen, TS, 2002) |
"To study the effect of an angiotensin II type 1 receptor antagonist, losartan, on cytokine expression, kidney growth and renal scarring in experimental acute pyelonephritis." | 3.70 | Angiotensin II type 1 receptor antagonist (losartan) down-regulates transforming growth factor-beta in experimental acute pyelonephritis. ( Bakhiet, M; Brauner, A; Burman, LG; Jaremko, G; Khalil, A; Tullus, K, 2000) |
"Losartan, a recently developed nonpeptide angiotensin II (AII) receptor antagonist, was orally administered for 14 days to mice with viral myocarditis, beginning 7 days after encephalomyocarditis virus inoculation." | 3.69 | Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus. ( Araki, M; Imai, S; Kanda, T; Kobayashi, I; Murata, K; Suzuki, T, 1995) |
"We examined the mechanisms mediating hypertension in conscious rats during acute and chronic infusion of angiotensin II (ANG II) at pressor doses (50, 100, and 200 ng." | 3.69 | Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency. ( Blaine, EH; Dale, WE; Hasser, EM; Li, Q, 1996) |
"To assess the efficacy of losartan (2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphe nyl-4-yl)methyl]imidazole, potassium salt), an angiotensin II receptor antagonist, on acute myocardial ischemia, 36 four-month-old spontaneously hypertensive rats were used." | 3.69 | Losartan attenuates myocardial ischemia-induced ventricular arrythmias and reperfusion injury in spontaneously hypertensive rats. ( Ding, YA; Lee, YM; Peng, YY; Yen, MH, 1997) |
"When losartan was added to ACE-in treatment, there was no significant increase in A-II." | 2.69 | Safety, tolerability, and neurohormonal changes of the combination captopril plus losartan in the early postinfarction period: a pilot study. ( Bucca, V; Di Pasquale, P; Paterna, S; Scalzo, S, 1998) |
"Diagnosis of gout is established when typical monosodium urate crystals can be identified." | 2.44 | [Involvement of the foot in metabolic diseases]. ( Gerster, JC, 2007) |
"Contributions to the understanding of acute renal failure (ARF) pathogenesis have not been translated into an effective clinical therapy." | 1.35 | Effects of losartan pretreatment in an experimental model of ischemic acute kidney injury. ( Bobadilla, NA; Cortés-González, C; Cruz, C; Elías, MM; González-Bobadilla, Y; Molinas, SM; Monasterolo, LA; Trumper, L, 2009) |
"Losartan treatment also reduced AP-associated depletion of IkappaBbeta and elevation of phospho-NF-kappaB p65 protein expression as well as the enhanced nuclear kappaB binding activity and elevated levels of kappaB-related proteins." | 1.34 | Angiotensin II type 1 receptor-dependent nuclear factor-kappaB activation-mediated proinflammatory actions in a rat model of obstructive acute pancreatitis. ( Chan, YC; Leung, PS, 2007) |
"Losartan treatment was able to reduce all these parameters." | 1.34 | Effect of angiotensin AT1 receptor antagonist on D-galactosamine-induced acute liver injury. ( Chan, H; Leung, PS; Tam, MS, 2007) |
"Induction of acute pancreatitis was achieved by hyperstimulation of two intraperitoneal (i." | 1.32 | The role of the pancreatic renin-angiotensin system in acinar digestive enzyme secretion and in acute pancreatitis. ( Cheng, CH; Leung, PS; Tsang, SW, 2004) |
"Coxiella burnetii myocarditis is a rare but severe clinical form of acute Q fever." | 1.31 | [Acute myocardial failure in a young man: Q-fever myocarditis]. ( Climent, V; López, I; Manso, MI; Murcia, J; Reus, S; Tello, A, 2002) |
"Treatment with losartan resulted in significant decreases in plasma ANF and N-terminal proANF, whereas BNP did not change." | 1.30 | Cardiac secretion of atrial and brain natriuretic peptides in acute ischaemic heart failure in pigs: effect of angiotensin II receptor antagonism. ( Djøseland, O; Hall, C; Karlberg, BE; Klinge, R, 1997) |
"Both enalapril and losartan treatment reduced the acute albuminuria, measured 1 day after injection of a monoclonal antibody against aminopeptidase A, by 91% and 83%, respectively." | 1.29 | Inhibition of aminopeptidase A activity causes an acute albuminuria in mice: an angiotensin II-mediated effect? ( Assmann, KJ; de Jong, AS; Dijkman, HB; Koene, RA; Mentzel, S; van Son, JP; Wetzels, JF, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 12 (27.91) | 18.2507 |
2000's | 21 (48.84) | 29.6817 |
2010's | 7 (16.28) | 24.3611 |
2020's | 3 (6.98) | 2.80 |
Authors | Studies |
---|---|
Yokota, T | 1 |
Koiwa, H | 1 |
Matsushima, S | 1 |
Tsujinaga, S | 1 |
Naya, M | 1 |
Morisaki, H | 1 |
Morisaki, T | 1 |
Xin, LH | 1 |
Liu, R | 1 |
Yang, XW | 1 |
Mohebbati, R | 1 |
Kamkar-Del, Y | 1 |
Shafei, MN | 1 |
Milewicz, DM | 1 |
Ramirez, F | 1 |
Srivastava, A | 1 |
Mathur, AD | 1 |
Stamatelopoulos, K | 1 |
Bramos, D | 1 |
Manios, E | 1 |
Alexaki, E | 1 |
Kaladaridou, A | 1 |
Georgiopoulos, G | 1 |
Koroboki, E | 1 |
Kolyviras, A | 1 |
Stellos, K | 1 |
Zakopoulos, N | 1 |
Toumanidis, S | 1 |
Okawada, M | 1 |
Wilson, MW | 1 |
Larsen, SD | 1 |
Lipka, E | 1 |
Hillfinger, J | 1 |
Teitelbaum, DH | 1 |
Molinas, SM | 1 |
Cortés-González, C | 1 |
González-Bobadilla, Y | 1 |
Monasterolo, LA | 1 |
Cruz, C | 1 |
Elías, MM | 1 |
Bobadilla, NA | 1 |
Trumper, L | 1 |
Klinge, R | 1 |
Djøseland, O | 1 |
Karlberg, BE | 1 |
Hall, C | 1 |
Cecconello, AL | 1 |
Raineki, C | 1 |
Sebben, V | 1 |
Lucion, AB | 1 |
Sanvitto, GL | 1 |
Hong, KS | 1 |
Kang, DW | 1 |
Bae, HJ | 1 |
Kim, YK | 1 |
Han, MK | 1 |
Park, JM | 1 |
Rha, JH | 1 |
Lee, YS | 1 |
Koo, JS | 1 |
Cho, YJ | 1 |
Kwon, SU | 1 |
Kim, SE | 1 |
Park, SH | 1 |
Kim, KS | 1 |
Abraham, D | 1 |
Williams, B | 1 |
Violin, JD | 1 |
Mao, L | 1 |
Rockman, HA | 1 |
Hvistendahl, JJ | 1 |
Pedersen, TS | 1 |
Djurhuus, JC | 1 |
Pedersen, EB | 1 |
Frøkiaer, J | 1 |
Murcia, J | 1 |
Reus, S | 1 |
Climent, V | 1 |
Manso, MI | 1 |
López, I | 1 |
Tello, A | 1 |
Fisher, AA | 1 |
Bassett, ML | 1 |
Richter, MH | 1 |
Richter, HR | 1 |
Olbrich, HG | 1 |
Mohr, FW | 1 |
Jego, C | 1 |
Michaut, V | 1 |
Graffin, B | 1 |
Paris, JF | 1 |
Carli, P | 1 |
Marshall, RP | 1 |
Gohlke, P | 1 |
Chambers, RC | 1 |
Howell, DC | 1 |
Bottoms, SE | 1 |
Unger, T | 1 |
McAnulty, RJ | 1 |
Laurent, GJ | 1 |
Dragun, D | 1 |
Bräsen, JH | 1 |
Schönemann, C | 1 |
Fritsche, L | 1 |
Budde, K | 1 |
Neumayer, HH | 1 |
Luft, FC | 1 |
Wallukat, G | 1 |
Rosário, LB | 1 |
Rocha, I | 1 |
Silva-Carvalho, L | 1 |
Tsang, SW | 1 |
Cheng, CH | 1 |
Leung, PS | 3 |
Ueland, T | 1 |
Aukrust, P | 1 |
Yndestad, A | 1 |
Otterdal, K | 1 |
Frøland, SS | 1 |
Dickstein, K | 1 |
Kjekshus, J | 1 |
Gullestad, L | 1 |
Damås, JK | 1 |
Rysä, J | 1 |
Aro, J | 1 |
Ruskoaho, H | 1 |
Tokuyama, H | 1 |
Kelly, DJ | 1 |
Zhang, Y | 1 |
Gow, RM | 1 |
Gilbert, RE | 1 |
Chan, YC | 1 |
Messadi-Laribi, E | 1 |
Griol-Charhbili, V | 1 |
Pizard, A | 1 |
Vincent, MP | 1 |
Heudes, D | 1 |
Meneton, P | 1 |
Alhenc-Gelas, F | 1 |
Richer, C | 1 |
Chan, H | 1 |
Tam, MS | 1 |
Gerster, JC | 1 |
Miyazaki, A | 1 |
Kitaichi, N | 1 |
Ohgami, K | 1 |
Iwata, D | 1 |
Jin, XH | 1 |
Iwabuchi, K | 1 |
Morohashi, T | 1 |
Ohno, S | 1 |
Onoé, K | 1 |
Araki, M | 1 |
Kanda, T | 1 |
Imai, S | 1 |
Suzuki, T | 1 |
Murata, K | 1 |
Kobayashi, I | 1 |
Baboolal, K | 1 |
Meyer, TW | 2 |
Pimentel, JL | 1 |
Wang, S | 1 |
Martinez-Maldonado, M | 1 |
Li, Q | 1 |
Dale, WE | 1 |
Hasser, EM | 1 |
Blaine, EH | 1 |
Mentzel, S | 1 |
Assmann, KJ | 1 |
Dijkman, HB | 1 |
de Jong, AS | 1 |
van Son, JP | 1 |
Wetzels, JF | 1 |
Koene, RA | 1 |
Morrell, NW | 1 |
Lee, YM | 1 |
Peng, YY | 1 |
Ding, YA | 1 |
Yen, MH | 1 |
Bosch, X | 1 |
Birck, R | 1 |
Keim, V | 1 |
Fiedler, F | 1 |
van der Woude, FJ | 1 |
Rohmeiss, P | 1 |
Di Pasquale, P | 1 |
Bucca, V | 1 |
Scalzo, S | 1 |
Paterna, S | 1 |
Georgiev, V | 1 |
Opitz, M | 1 |
Khalil, A | 1 |
Tullus, K | 1 |
Bakhiet, M | 1 |
Burman, LG | 1 |
Jaremko, G | 1 |
Brauner, A | 1 |
Pagtalunan, ME | 1 |
Olson, JL | 1 |
Dalmay, F | 1 |
Mazouz, H | 1 |
Allard, J | 1 |
Pesteil, F | 1 |
Achard, JM | 1 |
Fournier, A | 1 |
3 reviews available for losartan and Acute Disease
Article | Year |
---|---|
Therapies for Thoracic Aortic Aneurysms and Acute Aortic Dissections.
Topics: Acute Disease; Angiotensin II; Animals; Aortic Aneurysm, Thoracic; Aortic Dissection; Humans; Losart | 2019 |
Acute pancreatitis associated with angiotensin II receptor antagonists.
Topics: Acute Disease; Adult; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; | 2002 |
[Involvement of the foot in metabolic diseases].
Topics: Achilles Tendon; Acute Disease; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Apatites; Chon | 2007 |
3 trials available for losartan and Acute Disease
Article | Year |
---|---|
Effect of cilnidipine vs losartan on cerebral blood flow in hypertensive patients with a history of ischemic stroke: a randomized controlled trial.
Topics: Acute Disease; Aged; Angiotensin II Type 1 Receptor Blockers; Brain; Brain Ischemia; Calcium Channel | 2010 |
Soluble CD40 ligand in acute and chronic heart failure.
Topics: Acute Disease; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme I | 2005 |
Safety, tolerability, and neurohormonal changes of the combination captopril plus losartan in the early postinfarction period: a pilot study.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Humans; Losartan; Male; | 1998 |
37 other studies available for losartan and Acute Disease
Article | Year |
---|---|
Loeys-Dietz Cardiomyopathy? Long-term Follow-up After Onset of Acute Decompensated Heart Failure.
Topics: Acute Disease; Bisoprolol; Cardiomegaly; Cardiomyopathies; Cardiovascular Agents; Echocardiography; | 2022 |
Losartan promotes myocardial apoptosis after acute myocardial infarction in rats through inhibiting Ang II-induced JAK/STAT pathway.
Topics: Acute Disease; Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Disease Models, Animal; | 2020 |
The Possible Regulatory Mechanisms of Aqueous, Ethyl Acetate and NHexane Fractions of the Ribes khorassanicum Extract on Acute Hypertension in Rats.
Topics: Acetates; Acute Disease; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiovas | 2021 |
Losartan Induced Acute Urticaria.
Topics: Acute Disease; Antihypertensive Agents; Humans; Losartan; Urticaria | 2019 |
Pleiotropic effects of the acute and chronic inhibition of the renin-angiotensin system in hypertensives.
Topics: Acute Disease; Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Case-Control S | 2014 |
Blockade of the renin-angiotensin system prevents acute and immunologically relevant colitis in murine models.
Topics: Acute Disease; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; An | 2016 |
Effects of losartan pretreatment in an experimental model of ischemic acute kidney injury.
Topics: Acute Disease; Acute Kidney Injury; Angiotensin II Type 1 Receptor Blockers; Animals; Kidney; Losart | 2009 |
Cardiac secretion of atrial and brain natriuretic peptides in acute ischaemic heart failure in pigs: effect of angiotensin II receptor antagonism.
Topics: Acute Disease; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; A | 1997 |
Effect of acute stress on sexual behavior in female rats: participation of the central angiotensinergic system.
Topics: Acute Disease; Amygdala; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Typ | 2010 |
β-Arrestin-biased AT1R stimulation promotes cell survival during acute cardiac injury.
Topics: Acute Coronary Syndrome; Acute Disease; Adaptor Proteins, Signal Transducing; Angiotensin II Type 1 | 2012 |
Losartan attenuates renal vasoconstriction in response to acute unilateral ureteral occlusion in pigs.
Topics: Acute Disease; Aldosterone; Angiotensin II; Animals; Glomerular Filtration Rate; Kidney; Losartan; P | 2002 |
[Acute myocardial failure in a young man: Q-fever myocarditis].
Topics: Acute Disease; Adult; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antibodies, Bacterial; Cardiomy | 2002 |
Two good reasons for an angiotensin-II type 1 receptor blockade with losartan after cardiac transplantation: reduction of incidence and severity of transplant vasculopathy.
Topics: Acute Disease; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Coronary Artery D | 2003 |
[Scleroderma renal crisis following withdrawal of therapy with losartan].
Topics: Acute Disease; Anti-Inflammatory Agents; Antihypertensive Agents; Causality; Female; Humans; Hyperte | 2003 |
Angiotensin II and the fibroproliferative response to acute lung injury.
Topics: Acute Disease; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antibiotics, Antineoplastic | 2004 |
Patients with steroid refractory acute vascular rejection develop agonistic antibodies targeting angiotensin II type 1 receptor.
Topics: Acute Disease; Adrenal Cortex Hormones; Angiotensin II Type 1 Receptor Blockers; Antibody Formation; | 2003 |
Effect of losartan microinjections into the NTS on the cardiovascular components of chemically evoked reflexes in a rabbit model of acute heart ischemia.
Topics: Acute Disease; Animals; Capsaicin; Chemoreceptor Cells; Disease Models, Animal; Female; Losartan; Ma | 2003 |
The role of the pancreatic renin-angiotensin system in acinar digestive enzyme secretion and in acute pancreatitis.
Topics: Acute Disease; Angiotensin II Type 1 Receptor Blockers; Animals; Ceruletide; Enzymes; Gene Expressio | 2004 |
Early left ventricular gene expression profile in response to increase in blood pressure.
Topics: Acute Disease; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Ag | 2006 |
Macrophage infiltration and cellular proliferation in the non-ischemic kidney and heart following prolonged unilateral renal ischemia.
Topics: Acute Disease; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Movement; Cell Proliferation; | 2007 |
Angiotensin II type 1 receptor-dependent nuclear factor-kappaB activation-mediated proinflammatory actions in a rat model of obstructive acute pancreatitis.
Topics: Acute Disease; Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; Inflammatio | 2007 |
Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia.
Topics: Acute Disease; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiotonic Agents; | 2007 |
Effect of angiotensin AT1 receptor antagonist on D-galactosamine-induced acute liver injury.
Topics: Acute Disease; Alanine Transaminase; Angiotensin II Type 1 Receptor Blockers; Animals; Chemical and | 2007 |
Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats.
Topics: Acute Disease; Angiotensin II Type 1 Receptor Blockers; Animals; Aqueous Humor; Autoimmune Diseases; | 2008 |
Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus.
Topics: Acute Disease; Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihyperten | 1995 |
Tubulointerstitial injury and impaired renal function after recovery from acute puromycin nephrosis.
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Glomer | 1995 |
Regulation of the renal angiotensin II receptor gene in acute unilateral ureteral obstruction.
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Down-R | 1994 |
Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency.
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; B | 1996 |
Inhibition of aminopeptidase A activity causes an acute albuminuria in mice: an angiotensin II-mediated effect?
Topics: Acute Disease; Albuminuria; Aminopeptidases; Angiotensin II; Angiotensin-Converting Enzyme Inhibitor | 1996 |
Use of pulsed-wave Doppler echocardiography to measure changes in MPAP. Is further validation required?
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhib | 1997 |
Losartan attenuates myocardial ischemia-induced ventricular arrythmias and reperfusion injury in spontaneously hypertensive rats.
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Ar | 1997 |
Losartan-induced acute pancreatitis.
Topics: Acute Disease; Adult; Antihypertensive Agents; Humans; Losartan; Male; Pancreatitis | 1997 |
Pancreatitis after losartan.
Topics: Acute Disease; Adult; Antihypertensive Agents; Diabetic Nephropathies; Female; Humans; Hypertension, | 1998 |
Participation of angiotensin receptors in acute hypoxia in mice. II. Effects of angiotensin II nonpeptide receptor ligands losartan (DuP-753) and PD-123319.
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; D | 1999 |
Angiotensin II type 1 receptor antagonist (losartan) down-regulates transforming growth factor-beta in experimental acute pyelonephritis.
Topics: Acute Disease; Angiotensin Receptor Antagonists; Animals; Down-Regulation; Female; Losartan; Mice; M | 2000 |
Contribution of angiotensin II to late renal injury after acute ischemia.
Topics: Acute Disease; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Progressio | 2000 |
Non-AT(1)-receptor-mediated protective effect of angiotensin against acute ischaemic stroke in the gerbil.
Topics: Acute Disease; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; B | 2001 |